Remote Ischemic Preconditioning for Carotid Endarterectomy (RIP-CEA)
Primary Purpose
Carotid Stenosis, Endarterectomy, Carotid
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Remote Ischemic Preconditioning
Sponsored by
About this trial
This is an interventional prevention trial for Carotid Stenosis
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing carotid endarterectomy
- Indication for surgery must be symptomatic disease with >50% stenosis by duplex ultrasound or asymptomatic disease with >60% stenosis by duplex ultrasound
Exclusion Criteria:
- Lack of radial pulse on either arm
- Known Deep venous thrombosis (DVT) in arm
- Arteriovenous fistula or graft in both arms
- Diagnosed hypercoagulable state
- Pre-existing lymphedema or axillary node dissection both arms
- Diagnosis of dementia, intellectual disability, or mental illness including depression, anxiety, or schizophrenia
- Simultaneous coronary artery bypass grafting
Sites / Locations
- UPMC
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Usual Care
Remote Ischemic Preconditioning
Arm Description
Patients in the usual care arm will undergo CEA without RIPC.
Patients in the RIPC arm will undergo CEA with RIPC.
Outcomes
Primary Outcome Measures
Immediate change in Neurocognitive function
Montreal cognitive assessment
Longterm change in Neurocognitive function
Montreal cognitive assessment
Secondary Outcome Measures
S100-beta biomarker
serum level of S100-beta
Troponin
serum troponin level
Stroke
Stroke diagnosed by MRI findings of new stroke (obtained if symptomatic)
Neuron specific enolase (NSE) biomarker
Serum level of NSE
Adverse cardiac events
Any new myocardial infarction, new arrhythmia, or new onset heart failure
Severity of stroke
National Institute of Health Stroke Scale
Full Information
NCT ID
NCT02808754
First Posted
June 16, 2016
Last Updated
February 6, 2019
Sponsor
University of Pittsburgh
1. Study Identification
Unique Protocol Identification Number
NCT02808754
Brief Title
Remote Ischemic Preconditioning for Carotid Endarterectomy
Acronym
RIP-CEA
Official Title
Remote Ischemic Preconditioning for Carotid Endarterectomy
Study Type
Interventional
2. Study Status
Record Verification Date
February 2019
Overall Recruitment Status
Completed
Study Start Date
December 2016 (undefined)
Primary Completion Date
January 2019 (Actual)
Study Completion Date
January 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pittsburgh
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This is a randomized controlled trial designed to test an intervention (Remote ischemic preconditioning) in patients undergoing carotid endarterectomy (CEA) for carotid artery stenosis (CAS). The outcomes of interest include neurocognitive function, cardiac complications, and biomarkers of brain ischemia.
Detailed Description
Multiple large, high quality randomized trials have shown carotid endarterectomy (CEA) is effective in decreasing future risk of stroke in patients with carotid artery stenosis. Outcomes after carotid endarterectomy have improved over time. The major risks including stroke and myocardial infarction (MI) are rare (<3% stroke and 4% for MI. However, subtle degrees of cerebral ischemia and myocardial injury are more common. Research is now focused finding ways to reduce these subclinical adverse effects of CEA.
Due to its high metabolic activity, the brain is especially vulnerable to periods of ischemia during carotid cross clamping. Ischemic tolerance has been demonstrated after direct ischemic conditioning in the brain. However, direct conditioning is difficult and potentially dangerous when is comes to carotid interventions making remote ischemic preconditioning an attractive alternative. In animal models, remote ischemic preconditioning (RIPC) has been shown to produce an equivalent response to direct neuronal conditioning at the cellular level.
The precise mechanisms underlying the phenomenon of RIPC have yet to be fully elucidated. However, It is likely that both neural and humoral mechanisms are at play. Multiple studies have shown decreased levels of inflammatory markers in brains of animal models undergoing RIPC and then middle cerebral artery occlusion.
There has only been one study of RIPC in carotid endarterectomy so far. Patients were randomized to 10 min ischemia on each leg prior to clamping the carotid. Primary outcome was significant postoperative deterioration in saccadic latency determined by quantitative oculometry (time taken to respond and fix on a visual stimulus that appears suddenly). Additionally, troponins were drawn up to 48 hours post operatively. There was deterioration in quantitative oculometry in 8/25 RIPC and 16/30 control (p=0.11) and no difference in troponins. However this was a small number of patients.
Major clinical events such as stroke or MI are uncommon following CEA. This hampers the assessment of new, novel interventions as any trial would require several thousand patients to detect a useful clinical effect. The only alternative is to use surrogate end points to obtain "proof of concept" justifying larger trials. Several serum markers of neuronal damage such as S100-beta and neuron-specific enolase have been identified but are not reliable or specific enough to be used clinically. Another surrogate that is directly related to the concept of subtle degrees of neuronal ischemia occurring during CEA is neurocognitive function.
20-25% of patients have been shown to experience significant cognitive decline following CEA. This has been correlated with findings of ischemia on diffusion weighted MRI in patients after CEA indicating that local ischemia and microemboli are responsible for this decline. Thus, neurocognitive testing before and after carotid revascularization may be an ideal surrogate end point to study in remote ischemic preconditioning and it's potential to mediate the subtle degree of neuronal ischemia produced during carotid revascularization. However, neurocognitive function is also an endpoint with clinical relevance to patients.
This study will be a double armed randomized trial. The treatment arm will be Remote ischemic preconditioning and the Control arm will be Usual care. Intervention allocation ratio will be 1:1 RIPC:usual care. Randomization strategy will be a using a 1:1 fixed block of 4 randomization stratified by symptom status and age. Those randomized to RIPC will undergo a standard protocol of 4 cycles of 5 minutes of forearm ischemia with 5 minutes of reperfusion requiring 35 minutes for an application. Forearm ischemia will be induced by a blood pressure cuff inflated to 200 millimeters of mercury (mmHg) or at least 15mmHg higher than the systolic pressure if systolic > 185mmHg or until the radial pulse is obliterated. This can occur during anesthesia induction and incision/dissection prior to manipulation or clamping of the carotid.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Carotid Stenosis, Endarterectomy, Carotid
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
86 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Patients in the usual care arm will undergo CEA without RIPC.
Arm Title
Remote Ischemic Preconditioning
Arm Type
Experimental
Arm Description
Patients in the RIPC arm will undergo CEA with RIPC.
Intervention Type
Procedure
Intervention Name(s)
Remote Ischemic Preconditioning
Intervention Description
Those randomized to RIPC will undergo a standard protocol of 4 cycles of 5 minutes of forearm ischemia with 5 minutes of reperfusion requiring 35 minutes for an application. Forearm ischemia will be induced by a blood pressure cuff inflated to 200mmHg or at least 15mmHg higher than the systolic pressure if systolic > 185mmHg or until the radial pulse is obliterated. This can occur during anesthesia induction and incision/dissection prior to manipulation or clamping of the carotid.
Primary Outcome Measure Information:
Title
Immediate change in Neurocognitive function
Description
Montreal cognitive assessment
Time Frame
1 month before surgery and post operative day 1
Title
Longterm change in Neurocognitive function
Description
Montreal cognitive assessment
Time Frame
1 month before surgery and 1 month post operatively
Secondary Outcome Measure Information:
Title
S100-beta biomarker
Description
serum level of S100-beta
Time Frame
Post operative day one
Title
Troponin
Description
serum troponin level
Time Frame
post operative day one
Title
Stroke
Description
Stroke diagnosed by MRI findings of new stroke (obtained if symptomatic)
Time Frame
within 30 days post operative
Title
Neuron specific enolase (NSE) biomarker
Description
Serum level of NSE
Time Frame
Post operative day one
Title
Adverse cardiac events
Description
Any new myocardial infarction, new arrhythmia, or new onset heart failure
Time Frame
30 days postoperative
Title
Severity of stroke
Description
National Institute of Health Stroke Scale
Time Frame
30 days postoperative
10. Eligibility
Sex
All
Minimum Age & Unit of Time
55 Years
Maximum Age & Unit of Time
95 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients undergoing carotid endarterectomy
Indication for surgery must be symptomatic disease with >50% stenosis by duplex ultrasound or asymptomatic disease with >60% stenosis by duplex ultrasound
Exclusion Criteria:
Lack of radial pulse on either arm
Known Deep venous thrombosis (DVT) in arm
Arteriovenous fistula or graft in both arms
Diagnosed hypercoagulable state
Pre-existing lymphedema or axillary node dissection both arms
Diagnosis of dementia, intellectual disability, or mental illness including depression, anxiety, or schizophrenia
Simultaneous coronary artery bypass grafting
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Natalie Sridharan, MD
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
UPMC
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
12531577
Citation
Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, Warlow CP, Barnett HJ; Carotid Endarterectomy Trialists' Collaboration. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003 Jan 11;361(9352):107-16. doi: 10.1016/s0140-6736(03)12228-3.
Results Reference
background
PubMed Identifier
15319725
Citation
LaMuraglia GM, Brewster DC, Moncure AC, Dorer DJ, Stoner MC, Trehan SK, Drummond EC, Abbott WM, Cambria RP. Carotid endarterectomy at the millennium: what interventional therapy must match. Ann Surg. 2004 Sep;240(3):535-44; discussion 544-6. doi: 10.1097/01.sla.0000137142.26925.3c.
Results Reference
background
PubMed Identifier
16682166
Citation
Kragsterman B, Parsson H, Lindback J, Bergqvist D, Bjorck M; Swedish Vascular Registry (Swedvasc). Outcomes of carotid endarterectomy for asymptomatic stenosis in Sweden are improving: Results from a population-based registry. J Vasc Surg. 2006 Jul;44(1):79-85. doi: 10.1016/j.jvs.2006.03.003. Epub 2006 May 6.
Results Reference
background
PubMed Identifier
18193707
Citation
Dellagrammaticas D, Lewis S, Colam B, Rothwell PM, Warlow CP, Gough MJ; GALA trial collaborators. Carotid endarterectomy in the UK: acceptable risks but unacceptable delays. Clin Med (Lond). 2007 Dec;7(6):589-92. doi: 10.7861/clinmedicine.7-6-589.
Results Reference
background
PubMed Identifier
23451902
Citation
Inoue T, Ohwaki K, Tamura A, Tsutsumi K, Saito I, Saito N. Subclinical ischemia verified by somatosensory evoked potential amplitude reduction during carotid endarterectomy: negative effects on cognitive performance. J Neurosurg. 2013 May;118(5):1023-9. doi: 10.3171/2013.1.JNS121668. Epub 2013 Mar 1.
Results Reference
background
PubMed Identifier
18258156
Citation
Faries PL, DeRubertis B, Trocciola S, Karwowski J, Kent KC, Chaer RA. Ischemic preconditioning during the use of the PercuSurge occlusion balloon for carotid angioplasty and stenting. Vascular. 2008 Jan-Feb;16(1):1-9. doi: 10.2310/6670.2008.00012.
Results Reference
background
PubMed Identifier
17151832
Citation
Steiger HJ, Hanggi D. Ischaemic preconditioning of the brain, mechanisms and applications. Acta Neurochir (Wien). 2007 Jan;149(1):1-10. doi: 10.1007/s00701-006-1057-1. Epub 2006 Dec 14.
Results Reference
background
PubMed Identifier
16342612
Citation
Vlasov TD, Korzhevskii DE, Polyakova EA. Ischemic preconditioning of the rat brain as a method of endothelial protection from ischemic/repercussion injury. Neurosci Behav Physiol. 2005 Jul;35(6):567-72. doi: 10.1007/s11055-005-0095-0.
Results Reference
background
PubMed Identifier
18456674
Citation
Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res. 2008 Aug 1;79(3):377-86. doi: 10.1093/cvr/cvn114. Epub 2008 May 2.
Results Reference
background
PubMed Identifier
25072112
Citation
Gonzalez NR, Connolly M, Dusick JR, Bhakta H, Vespa P. Phase I clinical trial for the feasibility and safety of remote ischemic conditioning for aneurysmal subarachnoid hemorrhage. Neurosurgery. 2014 Nov;75(5):590-8; discussion 598. doi: 10.1227/NEU.0000000000000514.
Results Reference
background
PubMed Identifier
18783958
Citation
Walsh SR, Tang TY, Kullar P, Jenkins DP, Dutka DP, Gaunt ME. Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur J Cardiothorac Surg. 2008 Nov;34(5):985-94. doi: 10.1016/j.ejcts.2008.07.062. Epub 2008 Sep 9.
Results Reference
background
PubMed Identifier
25152442
Citation
Healy DA, Clarke Moloney M, McHugh SM, Grace PA, Walsh SR. Remote ischaemic preconditioning as a method for perioperative cardioprotection: concepts, applications and future directions. Int J Surg. 2014 Oct;12(10):1093-9. doi: 10.1016/j.ijsu.2014.08.352. Epub 2014 Aug 21.
Results Reference
background
PubMed Identifier
25653117
Citation
Le Page S, Bejan-Angoulvant T, Angoulvant D, Prunier F. Remote ischemic conditioning and cardioprotection: a systematic review and meta-analysis of randomized clinical trials. Basic Res Cardiol. 2015 Mar;110(2):11. doi: 10.1007/s00395-015-0467-8. Epub 2015 Feb 5.
Results Reference
background
PubMed Identifier
20484064
Citation
Walsh SR, Nouraei SA, Tang TY, Sadat U, Carpenter RH, Gaunt ME. Remote ischemic preconditioning for cerebral and cardiac protection during carotid endarterectomy: results from a pilot randomized clinical trial. Vasc Endovascular Surg. 2010 Aug;44(6):434-9. doi: 10.1177/1538574410369709. Epub 2010 May 18.
Results Reference
background
PubMed Identifier
14633290
Citation
Sahlein DH, Heyer EJ, Rampersad A, Winfree CJ, Solomon RA, Benvenisty AI, Quest DO, Du E, Connolly ES. Failure of intraoperative jugular bulb S-100B and neuron-specific enolase sampling to predict cognitive injury after carotid endarterectomy. Neurosurgery. 2003 Dec;53(6):1243-9 discussion 1249-50. doi: 10.1227/01.neu.0000093493.16850.11.
Results Reference
background
PubMed Identifier
11846900
Citation
Connolly ES Jr, Winfree CJ, Rampersad A, Sharma R, Mack WJ, Mocco J, Solomon RA, Todd G, Quest DO, Stern Y, Heyer EJ. Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy. Neurosurgery. 2001 Nov;49(5):1076-82; discussion 1082-3. doi: 10.1097/00006123-200111000-00010.
Results Reference
background
PubMed Identifier
10794336
Citation
Rasmussen LS, Christiansen M, Johnsen J, Gronholdt ML, Moller JT. Subtle brain damage cannot be detected by measuring neuron-specific enolase and S-100beta protein after carotid endarterectomy. J Cardiothorac Vasc Anesth. 2000 Apr;14(2):166-70. doi: 10.1016/s1053-0770(00)90012-0.
Results Reference
background
PubMed Identifier
9341703
Citation
Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke. 1997 Oct;28(10):1956-60. doi: 10.1161/01.str.28.10.1956.
Results Reference
background
PubMed Identifier
11843692
Citation
Heyer EJ, Sharma R, Rampersad A, Winfree CJ, Mack WJ, Solomon RA, Todd GJ, McCormick PC, McMurtry JG, Quest DO, Stern Y, Lazar RM, Connolly ES. A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol. 2002 Feb;59(2):217-22. doi: 10.1001/archneur.59.2.217.
Results Reference
background
PubMed Identifier
16639318
Citation
Mocco J, Wilson DA, Komotar RJ, Zurica J, Mack WJ, Halazun HJ, Hatami R, Sciacca RR, Connolly ES Jr, Heyer EJ. Predictors of neurocognitive decline after carotid endarterectomy. Neurosurgery. 2006 May;58(5):844-50; discussion 844-50. doi: 10.1227/01.NEU.0000209638.62401.7E.
Results Reference
background
PubMed Identifier
21943640
Citation
Baracchini C, Mazzalai F, Gruppo M, Lorenzetti R, Ermani M, Ballotta E. Carotid endarterectomy protects elderly patients from cognitive decline: a prospective study. Surgery. 2012 Jan;151(1):99-106. doi: 10.1016/j.surg.2011.06.031. Epub 2011 Sep 22.
Results Reference
background
PubMed Identifier
26070604
Citation
Qu L, Feng J, Zou S, Bai J, Hu Z, Guo M, Jing Z. Improved visual, acoustic, and neurocognitive functions after carotid endarterectomy in patients with minor stroke from severe carotid stenosis. J Vasc Surg. 2015 Sep;62(3):635-44.e2. doi: 10.1016/j.jvs.2015.04.401. Epub 2015 Jun 10.
Results Reference
background
PubMed Identifier
17803842
Citation
Wilson DA, Mocco J, D'Ambrosio AL, Komotar RJ, Zurica J, Kellner CP, Hahn DK, Connolly ES, Liu X, Imielinska C, Heyer EJ. Post-carotid endarterectomy neurocognitive decline is associated with cerebral blood flow asymmetry on post-operative magnetic resonance perfusion brain scans. Neurol Res. 2008 Apr;30(3):302-6. doi: 10.1179/016164107X230540. Epub 2007 Sep 4.
Results Reference
background
PubMed Identifier
18723423
Citation
De Rango P, Caso V, Leys D, Paciaroni M, Lenti M, Cao P. The role of carotid artery stenting and carotid endarterectomy in cognitive performance: a systematic review. Stroke. 2008 Nov;39(11):3116-27. doi: 10.1161/STROKEAHA.108.518357. Epub 2008 Aug 21.
Results Reference
background
PubMed Identifier
24393665
Citation
Paraskevas KI, Lazaridis C, Andrews CM, Veith FJ, Giannoukas AD. Comparison of cognitive function after carotid artery stenting versus carotid endarterectomy. Eur J Vasc Endovasc Surg. 2014 Mar;47(3):221-31. doi: 10.1016/j.ejvs.2013.11.006. Epub 2013 Nov 28.
Results Reference
background
PubMed Identifier
25933475
Citation
Wang Q, Zhou M, Zhou Y, Ji J, Raithel D, Qiao T. Effects of Carotid Endarterectomy on Cerebral Reperfusion and Cognitive Function in Patients with High Grade Carotid Stenosis: A Perfusion Weighted Magnetic Resonance Imaging Study. Eur J Vasc Endovasc Surg. 2015 Jul;50(1):5-12. doi: 10.1016/j.ejvs.2015.03.032. Epub 2015 Apr 29.
Results Reference
background
Learn more about this trial
Remote Ischemic Preconditioning for Carotid Endarterectomy
We'll reach out to this number within 24 hrs